538-75-0

Applied Filters:

Keyword:'538-75-0'

Showing 1-24 of 24 results for "538-75-0" within Technical Documents

Sigurjonsson, O., et al., PNAS (2005) 102:5227-5232. 66) Frappart, P., et al., Nature Medicine (2005) 11:538-544. 67) Peretto, P., et al., J. Comparative Neurology (2005) 487:407-427. 68) Scheffler, B., et

Programming data for Spectrophotometer and Spectroquant Test Kits

1.021 195 488 273 27.3 34.1 48.8 1.144 215 538 301 30.1 37.6 53.8 Absorbance (A) 10-mm Cell mg/l Ca mg/l CaCO3 mg/l CaO °d °e °f 0.051 0 0 0 0 0 0 0.063 5

Product Information Sheet-3333566001

11 934 520 001 dGTP 250 μl, 25 μmol, 100 mM 6,250 standard PCR assays of 20 μl each. 11 934 538 001 1,250 μl, 125 μmol, 100 mM 31,250 standard PCR assays of 20 μl each.

User Guide

mM 03 732 690 001 dGTP 250 μl, 25 μmol, 100 mM, 6,250 standard PCR assays of 20 μl each. 11 934 538 001 1,250 μl, 125 μmol, 100 mM, 31,250 standard PCR assays of 20 μl each. 11 969

Product Information Sheet-3333574001

11 934 520 001 dGTP 250 μl, 25 μmol, 100 mM 6,250 standard PCR assays of 20 μl each. 11 934 538 001 1,250 μl, 125 μmol, 100 mM 31,250 standard PCR assays of 20 μl each.

hKv4.3/hKChIP1-CHO K1 Recombinant Cell Line

inactivation gating of Kv4 channels by KChIP1, a small-molecular- weight calcium-binding protein. J Physiol 538, 691-706. Gutman, G.A., Chandy, K.G., Grissmer, S., Lazdunski, M., McKinnon, D, Pardo, L.A., Robertson

Protocol: GyroMark™ HT Human Insulin Gyros GyrolabTM xP Workstation Assay

112 6250 6376 6525 102 25000 25126 22654 90 Plasma 3 Neat 118 118 98 215 205 95 391 508 538 106 1563 1680 1825 109 6250 6368 6516 102

Protocol- HIGFMAG-52K

calibrated against the International Standards for IGF-I (WHO NIBSC 02/254) and IGF-II (WHO NIBSC 96/538) Reagents Volume Quantity Cat. No. IGF-I, II Standard* Lyophilized 1 vial HIGFMG-8052

Product Information Sheet-03353583910

03 732 690 001 dGTP 250 μl, 25 μmol, 100 mM 6,250 standard PCR assays of 20 μl each. 11 934 538 001 1,250 μl, 125 μmol, 100 mM 31,250 standard PCR assays of 20 μl each.

S&E Campaign Lab Tools - Tables for laboratory use

3422 5555 1.40 W 0, 2, 3, 4, 5, 6 [Xe] 4f 145d46s 2 75 186.21 3185 5596 1.46 Re 0, 2, 4, 6, 7 [Xe] 4f 145d56s 2 76 190.23 3033 5012 1.52

Tools and Tips for Analyzing Apoptosis: A Kit Selection Guide

90 ml 0 0 0 10 ml Cell Extract 80 ml 10 ml 0 0 10 ml Inhibitor-Treated Extract 60 ml 10 ml 0 20 ml 10 ml Purified Caspase 75 ml 0 15 ml 0 10

Calbiochem Biologics 30.2

OH OH O AGL 2263 A cell-permeable benzoxazolone-containing bioisostere of tyrphostin AG 538 (Cat. No. 658403) that acts as a potent, substrate-competitive, but not ATP-competitive, inhibitor

Drug Discovery Products & Services - Volume 1, 2014

Staurosporine at varying [ATP] EC 50 , n M [ATP] (µM) 0 100 200 300 400 500 600 700 800 900 0 25 50 75 100 125 150

Nitrate Spectroquant Test Kits Equivalency Report 2017

336.5 1.4688 1.0265 0.4935 1.4274 495.5 1.7642 2.4728 1.6474 1.7615 499.5 0.2316 334 0.0422 0.6924 538 1.7702 337 1.4694 1.0263 0.4956 1.4287 496 1.7704 2.4759 1.6517 1.7688 500 0.2311 335 0.0422 0.6916

Biologics 31.1

445; Razani B, et al. 2002. Mol. Cell Biol. 22, 2329; Woodman, S.E., et al. 2004. Neurology 62, 538. Anti-Caveolin-2, Rabbit pAb Polyclonal IgG, immunoaffinity-purified. Immunogen used was a synthetic

Calbiochem Biologics 31.1

HepaRG™ cells and their application to diverse endpoints

SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab Invest 83(4), 527-538 (2003). 56. Aninat C et al. Catecholamines induce an inflammatory response in human hepatocytes

Diabetes and Obesity

Optimized for inhibitor screening mTOR Signaling Linking cell growth & survival with cancer 0 25 50 75 100 Standard Rapamycin Rapamycin + FKBP12 Wortmannin m TO R Ac tiv ity

Research Focus - Volume 2, 2013

.25 2.00 1.75 1.50 1.25 1.00 0.75 0.50 0.25 0.00 Ab so rb an ce @ 4 50 n m 0 25 50 75 100 125 Phosphorylated GSK-3β (Ser9) Standard [units/mL] 16 FEATURED PRODUCTS

Protein Kinase and Related Tools Brochure

5 mg AG 370 658454 2 mg AG 490 658401 5 mg AG 494 658407 5 mg AG 527 658402 5 mg AG 538 658403 5 mg AG 555 658404 5 mg AG

Inhibitor Sourcebook 3rd Edition

5 mg I-OMe-AG 538 658417 [a-Cyano-(3-methoxy,4-hydroxy,5-iodo)cinnamoyl-(3’,4’- dihydroxyphenyl)ketone; Tyrphostin I-OMe-AG 538] A cell-permeable and reversible analog of AG 538 (Cat. No.658403) that

XP725 Antibody List 013M4793

26416, 1432, 81649 Mapk14,MAPK14 NP_036081.1,NP_620583.1,NP_112282.2 M y y y 537 Negative Control NA 538 p53 P5813 7157 TP53 NP_000537.3 M y n/d n/d 539 p53 P6874 7157 TP53 NP_000537.3 M y n/d n/d 540 phospho-p53

XP725 Antibody List

26416, 1432, 81649 Mapk14,MAPK14 NP_036081.1,NP_620583.1,NP_112282.2 M y y y 537 Negative Control 538 p53 P5813 7157 TP53 NP_000537.3 M y n/d n/d 539 p53 P6874 7157 TP53 NP_000537.3 M y n/d n/d 540 phospho-p53

Katalog neoLab

E-1388 5-15 mm 80 mm 5 pcs./pack Part no. Form max. span PU E-1395 round, 4 fingers 0-75 mm 5 pcs./pack Part no. Width Length PU E-1369 2